Abstract
Background: The effect of the Coronavirus Disease 2019 (COVID-19) pandemic on gram-negative bacteria nonsusceptibility to antibiotics is unclear. Methods: Between January 1, 2010, and December 31, 2021, the respiratory samples of intensive care unit patients at 3 University Hospitals in Brussels were retrieved. Based on the nonsusceptibility to antimicrobial classes, drug-resistance patterns were defined as multi-drug-resistant, extensively drug-resistant, and pan-drug-resistant. The study time frame was divided into 6 periods of 2 years each, and the impact of the COVID-19 pandemic (last period: 2020-2021) was assessed. Results: During the current study, 10,577 samples were identified from 5,889 patients. While a significant augmentation of multi-drug-resistant isolates was noticed once comparing 2 prepandemic periods (2012-2013 and 2014-2015), all 3 patterns of nonsusceptibility significantly increased, comparing the years before and throughout the COVID-19 pandemic (2018-2019 and 2020-2021). Globally, the greatest increase in antimicrobial nonsusceptibility, comparing the last 2 periods, was reported for piperacillin-tazobactam (from 28% to 38%). Pseudomonas aeruginosa was the most isolated species, and the most involved in the appearance of resistance, with an augmentation of nonsusceptibility percentage to meropenem of 22% (from 25% to 47%), between the prepandemic and the pandemic periods. Conclusions: The COVID-19 pandemic was associated with increasing trends of antimicrobial resistance in respiratory samples of patients admitted to the intensive care units in university hospitals with well-implemented antibiotic stewardship programs.
Original language | English |
---|---|
Pages (from-to) | 305-311 |
Number of pages <span style="color:red"p> <font size="1.5"> ✽ </span> </font> | 7 |
Journal | American journal of infection control |
Volume | 52 |
Issue number | 3 |
Early online date | 29 Aug 2023 |
DOIs | |
Publication status | Published - Mar 2024 |
Bibliographical note
Funding Information:We would like to express gratitude for the logistic support offered by the infectious diseases coordinating study team of UZ Brussel, CHU Saint Pierre and CHU Brugmann. Particularly, we would like to thank BYG4lab which provided the INFECTIO.GLOBAL software through which data collection was performed in CHU Saint Pierre and CHU Brugmann, Mr. Witdouck Arne (Data Manager—UZ Brussel) for its help on data cleaning, and Mr. Delforge Marc (Statistician—CHU Saint Pierre) for its check on statistical analyses.
Publisher Copyright:
© 2023 Association for Professionals in Infection Control and Epidemiology, Inc.
Keywords
- Gram-negative bacteria
- antibiotic susceptibility
- respiratory samples
- intensive care unit
- Ventilator-associated pneumonia
- Coronavirus Disease 2019